Canadian Solar ($CSIQ) Q2 2026 Earnings Analysis — Revenue Beats Estimates, but Losses and Margin Pressure Drag Stock After-Hours
Earnings Scorecard
Revenue: $1.21 billion (YoY -29%, estimate $1.136 billion) ✅ Beat
EPS (Earnings Per Share): GAAP net loss of $1.40 per share attributable to common shareholders · Adjusted estimate of -$1.23 is on a different basis and not directly comparable
Guidance: Maintained — Reaffirmed 2026 U.S. module shipments of 6.5–7.0 GW and storage of 4.5–5.5 GWh; Q3 revenue range of $1.3–$1.5 billion issued
Stock Reaction: After-hours -6.42% ($12.98) — As of 08-27 20:58 Korea Standard Time
The Positives
Energy storage shipments exceeded guidance: Combined internal and third-party executed project shipments reached 3.7 GWh, surpassing the 2.8–3.2 GWh guidance range.
Top end of revenue guidance: Net revenue of $1.21 billion landed at the upper end of the company's $1.0–$1.2 billion guidance range.
U.S. cell fab now operational: The first phase (nominal 2.1 GWp) of the Indiana heterojunction (HJT) cell fab has officially opened.
Of the 3.1 GW in module shipments, nearly half headed to North America, and the storage contract backlog stood at $3.5 billion, adding to medium- to long-term visibility. The U.S. manufacturing expansion is being read as a strategic pillar that outweighs near-term cost burdens.
The Negatives
Widening net loss attributable to common shareholders: GAAP net loss attributable to common shareholders of approximately $77 million, or $1.40 per share, deteriorated from the prior quarter.
Sharp gross margin decline: Gross margin of 13.9%, down sharply from 25.1% in the prior quarter and 29.8% a year ago.
Deferred project sale: The project development segment saw its planned sale pushed to the second half of the year, weighing on quarterly results.
The gross margin compression reflects the absence of the prior quarter's tariff refund benefit combined with normalization of storage margins. Operating expenses rose versus the prior quarter on ramp-up costs and logistics related to factory expansion.
What Management Said
Management framed U.S. manufacturing as a cornerstone of the medium-term strategy, noting that the ramp-up costs at the Indiana cell fab will weigh on profitability through year-end. Management also indicated that completing the deferred project sale in Q3 should lift project development segment results versus the prior quarter.
Market Reaction and Key Things to Watch
While revenue beat estimates, the combination of wider losses, margin normalization, and the deferred project sale has built up selling pressure ahead of the regular session.
Whether Q3 revenue and gross margin land within the company's guided ranges (revenue $1.3–$1.5 billion, gross margin 13.5–15.5%)
Whether the deferred project sale is actually booked in the second half
How much the Indiana cell fab ramp-up costs pressure margins
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.